Industry News
Shedding light on the Big Bang
Scientists at the ANU have developed a technology that may be used to study the universe's most violent events - the Big Bang and exploding stars. Their research shows that 'squeezed' light could be used to improve the performance of gravitational wave detectors.
[ + ]Synchrotron seeking commercial director
The Australian Synchrotron Project has progressed to the stage where it requires a commercial director to develop commercial and policy frameworks. [ + ]
New doubts cast on adult stem cell potential
Researchers at Stanford University Medical Center in the US have reported that they failed in attempts to coax adult blood-forming stem cells in mice into forming tissues other than blood and immune cells. [ + ]
AusBiotech recruiting for French devices and diagnostics tour
Up to 20 AusBiotech members are being offered the chance to take part in a medical devices and diagnostics mission in France this November 4-8, under the auspices of the French-Australian Industrial Research (FAIR) program. [ + ]
Chemeq picks up the pace in South Africa
Perth-based company Chemeq has started its push to introduce its polymeric antimicrobial drug for prevention of colibacillosis in pigs into South Africa, the first country to approve the veterinary product. [ + ]
From footy to neuroscience: CogState branches out
A Melbourne company, whose test to measure cognitive abilities counts AFL teams among its customers, is branching out into biotech to develop neuroscience therapeutics. [ + ]
Panbio finds R&D leader in its own backyard
Medical diagnostics company Panbio has headhunted Prof Stuart Hazell, dean of the University of Southern Queensland's science faculty, as its vice-president for R&D. [ + ]
Griffith, Monash researchers behind new start-up
Two leading Australian scientists - Prof Mark von Itzstein and Prof Ross Coppel - have helped form a new company to deliver novel pharmaceuticals for use against drug-resistant bacteria. [ + ]
Biocomm names Canadian as chief operating officer
Melbourne-based life science commercialisation company Biocomm Services has appointed former Calgary Innovation Centre (CIC) executive director Lawrence Bremner as its new chief operating officer. [ + ]
MSAC decision disappoints Sirtex CEO
The chief executive of Sydney-based company Sirtex has expressed disappointment with the Medical Services Advisory Committee (MSAC) following its surprise rejection of a subsidy application for the company's liver cancer treatment. [ + ]
Monash IRD creates mouse model for neuro disease
Researchers at the Monash Institute of Reproduction and Development have succeeded in creating a transgenic mouse model for Kennedy disease, a neurodegenerative disease that affects approximately 1 in 50,000 men. [ + ]
Australian technology helps create triple-seeding soybeans
A soybean variety developed in collaboration with James Cook University could double yields for Vietnamese farmers.
[ + ]Former GroPep CEO Ballard launches angel fund
A new business angel network, BioAngels Inc, has been launched in Adelaide by former GroPep CEO John Ballard. [ + ]
Virax to extend trials for HIV/AIDS therapy
Melbourne-based immune therapies company Virax Holdings has announced an extension to its Phase I/IIA clinical trial to further assess the potential of its HIV/AIDS therapy. [ + ]
Name change for Sydney institute
The Institute of Respiratory Medicine in Sydney has changed its name to the Woolcock Institute of Medical Research in honour of its founding director Prof Ann Woolcock AO. [ + ]